Search results
Showing 8401 to 8415 of 8900 results
Promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126)
This advice has been replaced by NICE HealthTech guidance 521.
This advice has been updated and replaced by NICE healthtech guidance 624.
Health app: ChatHealth communication platform in school nursing services (MIB130)
The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.
This advice has been updated and replaced by NICE healthtech guidance 553.
This advice has been updated and replaced by NICE medical technologies guidance 44.
Point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145)
This advice has been updated and replaced by NICE HealthTech guidance 531.
QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146)
This advice has been updated and replaced by NICE healthtech guidance 571.
PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)
This advice has been updated and replaced by NICE medical technologies guidance 43.
FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care (MIB114)
This advice has been updated and replaced by NICE medtech innovation briefing 224.
PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)
This advice has been updated and replaced by NICE medical technologies guidance 48.
AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)
This advice has been updated and replaced by NICE medtech innovation briefing 232.
Flow transcranial direct current stimulation for treating depression (MIB324)
May 2024: This medtech innovation briefing has been withdrawn. This is because the evidence for the technology has changed since it was published. NHS England no longer funds NICE to produce or maintain medtech innovation briefings, so these are no longer being reviewed.
This advice has been updated and replaced by NICE medical technologies guidance 47.
The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)
This advice has been updated and replaced by NICE guidance HTG441
EndoPredict gene expression profiling assay for assessing risk of breast cancer recurrence (MIB44)
This advice has been updated and replaced by NICE diagnostics guidance 34.